Therapeutic Solutions International, Inc. TSOI

TSOI Company Overview

Therapeutic Solutions International, Inc. (TSOI) is a U.S.-based biotechnology company focused on immunotherapy, regenerative medicine, and cell-based therapeutic development. The company operates primarily in the biopharmaceutical and life sciences sectors, with research activities centered on immune modulation, stem cell technologies, cancer immunotherapy, and inflammatory disease treatment. Public filings and corporate disclosures indicate that TSOI’s business model is driven by intellectual property development, preclinical and clinical-stage therapeutic programs, licensing opportunities, and strategic collaborations related to regenerative medicine platforms.

TSOI has historically concentrated on developing therapeutic candidates targeting conditions such as cancer, autoimmune disorders, traumatic brain injury, chronic inflammation, and infectious disease-related immune dysfunction. The company has also pursued nutraceutical and over-the-counter immune support products through affiliated operations. Its strategic positioning has emphasized proprietary cell therapy approaches and immune-regulatory technologies intended to address unmet medical needs. Based on available public sources, the company evolved from earlier biotechnology initiatives into a broader immunotherapy-focused organization with multiple patent filings and research partnerships supporting its development pipeline.